Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 3/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.48 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.47 |
| ▸ | EP300 | Q09472 | 1/20 | 0.42 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL809673 | 1.00 | — | — | |
| SCHEMBL5385627 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL29021072 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL6244976 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL6236349 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL959537 | 1.00 | — | — | |
| SCHEMBL2587492 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL7555214 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL6244348 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 | |
| SCHEMBL28322949 | 1.00 | TSHR (0.55) | TSHRTHRBFAAHTRPV1DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117187380-A | One-tube APOE genotyping detection kit and detection method thereof | 青岛瑞思德医学检验实验室有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-111141709-A | Humidity response supramolecular thin film material composition, supramolecular thin film, preparation method of supramolecular thin film and application of supramolecular thin film | 北京大学 | 2020-05-12 | — | — | CN | disclosed |
| EP-2249779-A2 | COSMETIC COMPOSITION COMPRISING A CATIONIC SURFACTANT COMPOUND, NOVEL COMPOUNDS, USE AS CONDITIONER AND COSMETIC TREATMENT METHOD | L'Oréal (FR) | 2010-11-17 | — | — | EP | disclosed |
| EP-2249780-A2 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L'Oréal (FR) | 2010-11-17 | — | — | EP | disclosed |
| WO-2010029267-A1 | COSMETIC COMPOSITION CONTAINING QUATERNARY AMMONIUM ESTERS AND THICKENING POLYMERS, AND USE FOR HAIR CONDITIONING | L'OREAL (FR) | 2010-03-18 | — | — | WO | disclosed |
| WO-2009101322-A2 | COSMETIC COMPOSITION COMPRISING A CATIONIC SURFACTANT COMPOUND, NOVEL COMPOUNDS, USE AS CONDITIONER AND COSMETIC TREATMENT METHOD | L'OREAL (FR) | 2009-08-20 | — | — | WO | disclosed |
| WO-2009101323-A2 | COSMETIC COMPOSITION IN THE FORM OF AN OIL-IN-WATER EMULSION CONTAINING A CATIONIC SURFACTANT OF THE QUATERNARY AMMONIUM ESTER TYPE DERIVED FROM 2-[2-(DIETHYLAMINO)ETHOXY]ETHANOL | L'OREAL (FR) | 2009-08-20 | — | — | WO | disclosed |
| WO-2009101321-A2 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L'OREAL (FR) | 2009-08-20 | — | — | WO | disclosed |
| US-20020173489-A1 | COMPOSITIONS CONTAINING A MIXTURE OF PHOSPHOROUS COMPOUNDS AND ALKYLGLYCEROLS | MAX-PLANCK-GESSELSCHAFT ZUR FORDERUNG DER WISSENSCHAFTER E.V. (DE) | 2002-11-21 | — | — | US | disclosed |
| US-5916884-A | CYTOTOXIC THERAPEUTIC COMPOUND; ANTITUMOR AGENT | MAX-PLANCK-GESELLSCHAFT ZUR FOEDERUNG DER WISSENSCHAFTEN (DE) | 1999-06-29 | — | — | US | disclosed |
| EP-0916343-A1 | use of alkzl phosphoric acid compounds for the treatment of psoriatic diseases | ASTA Medica Aktiengesellschaft (DE) | 1999-05-19 | — | — | EP | disclosed |
| US-5290769-A | Applying compositions for skin disorders | ASTA PHARMA AKTIENGESELLSCHAFT (DE) | 1994-03-01 | — | — | US | disclosed |
| EP-0248062-B1 | MEDICAMENTS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1992-05-06 | — | — | EP | disclosed |
| EP-0419998-A2 | Use of alkylphosphonic acid derivatives for the treatment of psoriasis | ASTA Medica Aktiengesellschaft (DE) | 1991-04-03 | — | — | EP | disclosed |
| EP-0248858-B1 | NOVEL PHOSPHO-COMPOUNDS AND MEDICAMENTS CONTAINING THESE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1990-02-28 | — | — | EP | disclosed |
| EP-0248858-A1 | NOVEL PHOSPHO-COMPOUNDS AND MEDICAMENTS CONTAINING THESE. | MAX PLANCK GESELLSCHAFT (DE) | 1987-12-16 | — | — | EP | disclosed |
| WO-1987003596-A2 | NOVEL PHOSPHO-COMPOUNDS AND MEDICAMENTS CONTAINING THESE | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSC (DE) | 1987-06-18 | — | — | WO | disclosed |
| EP-0225608-A2 | Medicine | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-06-16 | — | — | EP | disclosed |
| EP-0224925-A2 | Phosphorous compounds and medicines containing them | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1987-06-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020173489-A1 | COMPOSITIONS CONTAINING A MIXTURE OF PHOSPHOROUS COMPOUNDS AND ALKYLGLYCEROLS | PHOSPHO1, PLCG2, PPIP5K2 | TSHR 4720/4885THRB 4839/4885FAAH 455/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.